Nephros (NEPH) Accumulated Expenses (2010 - 2026)

Nephros' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $662000.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 9.78% year-over-year to $662000.0 in Q1 2026; TTM through Mar 2026 was $662000.0, a 9.78% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 1088.62% from the prior year.
• Accumulated Expenses retreated to $662000.0 in Q1 2026 per NEPH's latest filing, from $1.5 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $1.5 million in Q4 2025 and bottomed at $123000.0 in Q4 2024.
• The 5-year median for Accumulated Expenses is $435000.0 (2024), against an average of $538294.1.
• Across the five-year window, Accumulated Expenses slumped 77.09% in 2024 and soared 1088.62% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $285000.0 in 2022, then surged by 88.42% to $537000.0 in 2023, then slumped by 77.09% to $123000.0 in 2024, then surged by 1088.62% to $1.5 million in 2025, then slumped by 54.72% to $662000.0 in 2026.
• Per Business Quant, the three latest NEPH Accumulated Expenses figures stand at $662000.0 (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025).